Jane Street Portfolio holdings
Jane Street Group, founded in 2000 by Tim Reynolds, Rob Granieri, Marc Gerstein, and Michael Jenkins, is a New York City-based quantitative trading firm renowned for its technological prowess and collaborative problem-solving culture. Specializing in liquidity provision and market-making, it trades a vast array of financial products—including equities, bonds, options, and ETFs—across over 200 venues in 45 countries, handling trillions in securities annually. The firm, which employs over 2,600 people across offices in New York, London, Hong Kong, Amsterdam, Chicago, and Singapore, leverages advanced algorithms and a nearly 70-million-line OCaml codebase to dominate markets, notably ETFs, where it plays a critical role as an authorized participant. With net trading revenues exceeding $10 billion annually in recent years, including a record $10.6 billion in 2023, Jane Street has emerged as a secretive yet powerful force in global finance, outpacing traditional Wall Street giants like Goldman Sachs in trading profitability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI ACWI ETF
ACWI
|
+$825M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$813M |
| 3 |
Direxion Daily 20+ Year Treasury Bull 3X ETF
TMF
|
+$802M |
| 4 |
iShares MSCI India ETF
INDA
|
+$743M |
| 5 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$704M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.37B |
| 2 |
Microsoft
MSFT
|
+$2.08B |
| 3 |
NVIDIA
NVDA
|
+$1.74B |
| 4 |
Amazon
AMZN
|
+$1.08B |
| 5 |
Netflix
NFLX
|
+$803M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 2.41% |
| 2 | Consumer Discretionary | 1.14% |
| 3 | Financials | 1.02% |
| 4 | Healthcare | 0.75% |
| 5 | Industrials | 0.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
8776
PUT
Globalstar
GSAT
$10.8B
| $22.2K | ﹤0.01% |
1,007
+160
| +19% | +$3.87K |
|
8777
AEye
LIDR
$61.1M
| $22.2K | ﹤0.01% |
17,754
+6,449
| +57% | +$9.36K |
|
8778
Envoy Medical Warrant
COCHW
$574K
| $22.2K | ﹤0.01% |
208,165
| – | – |
|
|
KZR
8779
DELISTED
Kezar Life Sciences
KZR
| $22.2K | ﹤0.01% |
2,457
-4,486
| -65% | -$40.9K |
|
8780
TruGolf
TRUG
$1.02M
| $21.9K | ﹤0.01% |
+34
| New | +$68K |
|
8781
Inuvo
INUV
$17M
| $21.4K | ﹤0.01% |
6,278
-2,081
| -25% | -$8.72K |
|
8782
Arbe Robotics
ARBE
$94.2M
| $21.3K | ﹤0.01% |
+10,181
| New | +$19.5K |
|
8783
PUT
Clover Health Investments
CLOV
$2.51B
| $21.2K | ﹤0.01% |
26,700
+6,100
| +30% | +$5.55K |
|
8784
PUT
Ginkgo Bioworks
DNA
$521M
| $21.1K | ﹤0.01% |
455
-1,008
| -69% | -$52.2K |
|
8785
CALL
Bakkt Inc
BKKT
$337M
| $21.1K | ﹤0.01% |
1,832
-5,736
| -76% | -$154K |
|
8786
ENDRA Life Sciences
NDRA
$5.84M
| $20.9K | ﹤0.01% |
+21
| New | +$41.2K |
|
|
DMRA
8787
Damora Therapeutics, Inc. Ordinary Shares
DMRA
$1.84B
| $20.4K | ﹤0.01% |
+1,049
| New | +$18.6K |
|
8788
CALL
Microvision
MVIS
$78.9M
| $20.4K | ﹤0.01% |
740
-6,420
| -90% | -$218K |
|
|
BLUE
8789
PUT
DELISTED
bluebird bio
BLUE
| $20.4K | ﹤0.01% |
795
-11,180
| -93% | -$287K |
|
|
ZOM
8790
DELISTED
Zomedica Corp.
ZOM
| $19.8K | ﹤0.01% |
135,872
-191,047
| -58% | -$26.7K |
|
|
BIOR
8791
DELISTED
Biora Therapeutics, Inc. Common Stock
BIOR
| $19.6K | ﹤0.01% |
+1,778
| New | +$19.2K |
|
8792
SeaStar Medical
ICU
$13.1M
| $19.2K | ﹤0.01% |
105
+37
| +54% | +$7.25K |
|
|
EVGOW
8793
DELISTED
EVgo Inc Warrants
EVGOW
| $19.2K | ﹤0.01% |
101,340
-21
| -0% | -$4 |
|
8794
Boxlight
BOXL
$2.13M
| $19K | ﹤0.01% |
+162
| New | +$25.1K |
|
|
CMRX
8795
DELISTED
Chimerix, Inc.
CMRX
| $18.9K | ﹤0.01% |
17,796
-177,508
| -91% | -$185K |
|
|
LILM
8796
DELISTED
Lilium N.V. Class A Ordinary Shares
LILM
| $18.8K | ﹤0.01% |
19,568
-155,159
| -89% | -$144K |
|
|
HOOK
8797
DELISTED
HOOKIPA Pharma
HOOK
| $18.5K | ﹤0.01% |
+2,600
| New | +$18.5K |
|
|
AUROW
8798
Aurora Innovation Warrant
AUROW
$370M
| $18.4K | ﹤0.01% |
68,261
-56,774
| -45% | -$16.5K |
|
8799
Polar Power
POLA
$6.86M
| $17.9K | ﹤0.01% |
+4,613
| New | +$13.3K |
|
|
BNBX
8800
DELISTED
BNB PLUS CORP
BNBX
| $17.3K | ﹤0.01% |
+3
| New | +$25.7K |
|
Similar funds
Jane Street's Q1 2024 Portfolio in Review
As of Q1 2024, Jane Street held 10,498 positions worth $478B, up 25% from $384B the previous quarter. Its ten largest holdings account for 51% of the portfolio.
Jane Street deployed $55.3B of net new capital in Q1 2024, opening 1,391 new positions and adding to 3,225 existing holdings. Its largest new stake was iShares MSCI EAFE Value ETF: 9,907,136 shares worth $539M.
By sector, the portfolio is most concentrated in Technology at 2.4% of assets, down from 4.4% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $2.37B trimmed.
- Jane Street's largest Q1 2024 buy was iShares MSCI EAFE Value ETF: 9,907,136 shares worth $539M.
- Jane Street added most to iShares MSCI ACWI ETF in Q1 2024, an estimated $825M increase.
- Jane Street's biggest Q1 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.37B.
- Jane Street fully exited JPMorgan Ultra-Short Income ETF in Q1 2024, selling an estimated $302M.
- Jane Street's ten largest holdings make up 51% of its $478B portfolio in Q1 2024.
- Jane Street opened 1,391 new positions and closed 1,402 in Q1 2024.
- Jane Street's portfolio value rose 25% quarter-over-quarter to $478B.
Based on Jane Street's 13F filing for Q1 2024, filed 16 May 2024.